Literature DB >> 26882262

Sample size calculation for testing differences between cure rates with the optimal log-rank test.

Jianrong Wu1.   

Abstract

In this article, sample size calculations are developed for use when the main interest is in the differences between the cure rates of two groups. Following the work of Ewell and Ibrahim, the asymptotic distribution of the weighted log-rank test is derived under the local alternative. The optimal log-rank test under the proportional distributions alternative is discussed, and sample size formulas for the optimal and standard log-rank tests are derived. Simulation results show that the proposed formulas provide adequate sample size estimation for trial designs and that the optimal log-rank test is more efficient than the standard log-rank test, particularly when both cure rates and percentages of censoring are small.

Entities:  

Keywords:  Clinical trial; cure model; log-rank test; optimal test; sample size

Mesh:

Year:  2016        PMID: 26882262      PMCID: PMC5575886          DOI: 10.1080/10543406.2016.1148711

Source DB:  PubMed          Journal:  J Biopharm Stat        ISSN: 1054-3406            Impact factor:   1.051


  9 in total

1.  A nonparametric mixture model for cure rate estimation.

Authors:  Y Peng; K B Dear
Journal:  Biometrics       Date:  2000-03       Impact factor: 2.571

2.  Estimation in a Cox proportional hazards cure model.

Authors:  J P Sy; J M Taylor
Journal:  Biometrics       Date:  2000-03       Impact factor: 2.571

3.  A SAS macro for parametric and semiparametric mixture cure models.

Authors:  Fabien Corbière; Pierre Joly
Journal:  Comput Methods Programs Biomed       Date:  2006-12-08       Impact factor: 5.428

4.  The large sample distribution of the weighted log rank statistic under general local alternatives.

Authors:  M Ewell; J G Ibrahim
Journal:  Lifetime Data Anal       Date:  1997       Impact factor: 1.588

5.  A generalized F mixture model for cure rate estimation.

Authors:  Y Peng; K B Dear; J W Denham
Journal:  Stat Med       Date:  1998-04-30       Impact factor: 2.373

6.  A linear rank test for use when the main interest is in differences in cure rates.

Authors:  R J Gray; A A Tsiatis
Journal:  Biometrics       Date:  1989-09       Impact factor: 2.571

7.  Group sequential methods for comparison of cure rates in clinical trials.

Authors:  J W Lee; H N Sather
Journal:  Biometrics       Date:  1995-06       Impact factor: 2.571

8.  The use of mixture models for the analysis of survival data with long-term survivors.

Authors:  V T Farewell
Journal:  Biometrics       Date:  1982-12       Impact factor: 2.571

9.  Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684.

Authors:  J M Kirkwood; M H Strawderman; M S Ernstoff; T J Smith; E C Borden; R H Blum
Journal:  J Clin Oncol       Date:  1996-01       Impact factor: 44.544

  9 in total
  3 in total

1.  A novel sample size formula for the weighted log-rank test under the proportional hazards cure model.

Authors:  Xiaoping Xiong; Jianrong Wu
Journal:  Pharm Stat       Date:  2016-11-08       Impact factor: 1.894

2.  Are non-constant rates and non-proportional treatment effects accounted for in the design and analysis of randomised controlled trials? A review of current practice.

Authors:  Kim Jachno; Stephane Heritier; Rory Wolfe
Journal:  BMC Med Res Methodol       Date:  2019-05-16       Impact factor: 4.615

3.  The influence of body mass index on the survival of patients with melanoma. A cross-sectional study of 707 patients.

Authors:  Cesar Zepeda-Najar; Leonardo Saul Lino-Silva; Jazmin D Chávez-Hernandez; Rosa A Salcedo-Hernández; Johana P Jimenez-Sánchez; Carlos E Fernández-Sánchez; Carlos D Valdez-Aguilar
Journal:  Contemp Oncol (Pozn)       Date:  2021-03-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.